MX2010013790A - Composiciones y metodos para tratar inflamacion de corneas. - Google Patents

Composiciones y metodos para tratar inflamacion de corneas.

Info

Publication number
MX2010013790A
MX2010013790A MX2010013790A MX2010013790A MX2010013790A MX 2010013790 A MX2010013790 A MX 2010013790A MX 2010013790 A MX2010013790 A MX 2010013790A MX 2010013790 A MX2010013790 A MX 2010013790A MX 2010013790 A MX2010013790 A MX 2010013790A
Authority
MX
Mexico
Prior art keywords
compostions
methods
corneal inflammation
treating corneal
treating
Prior art date
Application number
MX2010013790A
Other languages
English (en)
Inventor
Pearlman Eric
Original Assignee
Univ Case Western Reserve
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Case Western Reserve filed Critical Univ Case Western Reserve
Publication of MX2010013790A publication Critical patent/MX2010013790A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Eyeglasses (AREA)

Abstract

Un método para tratar inflamación de corneas en un sujeto incluye administrar al sujeto una cantidad terapéuticameflte efectiva de un antagonista de TLR4.
MX2010013790A 2008-06-13 2009-06-15 Composiciones y metodos para tratar inflamacion de corneas. MX2010013790A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6129108P 2008-06-13 2008-06-13
US10149308P 2008-09-30 2008-09-30
PCT/US2009/047407 WO2009152517A1 (en) 2008-06-13 2009-06-15 Compostions and methods for treating corneal inflammation

Publications (1)

Publication Number Publication Date
MX2010013790A true MX2010013790A (es) 2011-03-21

Family

ID=41417157

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010013790A MX2010013790A (es) 2008-06-13 2009-06-15 Composiciones y metodos para tratar inflamacion de corneas.

Country Status (12)

Country Link
US (1) US9006210B2 (es)
EP (1) EP2294419B1 (es)
JP (1) JP5550641B2 (es)
KR (1) KR101359102B1 (es)
CN (1) CN102159950B (es)
AU (1) AU2009257259B2 (es)
BR (1) BRPI0915143A2 (es)
CA (1) CA2727847C (es)
EA (1) EA019437B1 (es)
IL (1) IL209947A (es)
MX (1) MX2010013790A (es)
WO (1) WO2009152517A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101473100B1 (ko) * 2013-05-30 2014-12-15 인제대학교 산학협력단 Ｅｂｖ 감염 인간각막상피세포를 이용한 혈관신생 질환용 세포 모델
US20180333461A1 (en) * 2014-12-08 2018-11-22 The University Of Queensland Methods and compositions for treating or preventing flavivirus infections
JP6778681B2 (ja) 2014-12-12 2020-11-04 ザ ファインスタイン インスティテュート フォー メディカル リサーチ Ｈｍｇｂ１媒介性炎症の治療
KR101745524B1 (ko) 2015-05-29 2017-06-12 아주대학교산학협력단 신규한 tlr2 길항제

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6239113B1 (en) * 1999-03-31 2001-05-29 Insite Vision, Incorporated Topical treatment or prevention of ocular infections
EP1218007B1 (en) 1999-09-13 2011-07-20 Bridge Pharma, Inc. Optically active isomers of ketotifen and therapeutically active metabolites thereof
US6719929B2 (en) 2000-02-04 2004-04-13 Novartis Ag Method for modifying a surface
US20060051821A1 (en) * 2003-02-12 2006-03-09 Rossignol Daniel P Methods and kits for use in the diagnosis and treatment of endotoxemia
CA2606727A1 (en) * 2005-05-13 2007-03-22 Eisai Co., Ltd. Lipid a analogs for treating oral and gastrointestinal mucositis
KR101382162B1 (ko) 2005-08-31 2014-04-07 에자이 알앤드디 매니지먼트 가부시키가이샤 리피드 ａ 유사체의 제조 방법
US10045953B2 (en) 2006-07-06 2018-08-14 Case Western Reserve University Ceramide composition and method of use
WO2008076804A2 (en) * 2006-12-13 2008-06-26 Case Western Reserve University Method of treating intrauterine inflammation

Also Published As

Publication number Publication date
KR101359102B1 (ko) 2014-02-05
CN102159950A (zh) 2011-08-17
CN102159950B (zh) 2014-12-17
EP2294419A1 (en) 2011-03-16
EA201071350A1 (ru) 2011-08-30
US20110105426A1 (en) 2011-05-05
JP2011524371A (ja) 2011-09-01
BRPI0915143A2 (pt) 2017-03-21
CA2727847C (en) 2014-08-05
KR20110026444A (ko) 2011-03-15
AU2009257259A1 (en) 2009-12-17
EP2294419B1 (en) 2013-08-14
AU2009257259B2 (en) 2013-05-02
EP2294419A4 (en) 2012-01-25
EA019437B1 (ru) 2014-03-31
WO2009152517A1 (en) 2009-12-17
IL209947A (en) 2014-07-31
IL209947A0 (en) 2011-02-28
CA2727847A1 (en) 2009-12-17
JP5550641B2 (ja) 2014-07-16
US9006210B2 (en) 2015-04-14

Similar Documents

Publication Publication Date Title
MY145769A (en) Method for treating or preventing systemic inflammation
MX346224B (es) Composiciones y metodos para el tratamiento de inflamacion cronica y enfermedades inflamatorias.
MX2011013201A (es) Composiciones para tratar adiccion a drogas y para mejorar comportamiento relacionado a la adiccion.
MY173215A (en) Acetylcysteine compositions and methods of use thereof
WO2009079451A3 (en) Compositions and methods of promoting wound healing
IN2015DN00450A (es)
MX2013003076A (es) Terapeuticos contra cancer de mama.
MX350745B (es) El uso de un compuesto de carbamoilo para el tratamiento del sindrome de fibromialgia.
MX2014000515A (es) Metodo de tratamiento de inflamacion e himpertencion secuestrante de gama -cetoaldehido.
WO2012071369A3 (en) A non-retinoid rbp4 antagonist for treatment of age-related macular degeneration and stargardt disease
WO2009048778A3 (en) Laminins, derivatives, and compositions including same and method for their therapeutic use
MX2018013715A (es) Composiciones acuosas de capsaicinoides que comprenden un analgesico y un vehiculo acuoso, y uso de las mismas para el tratamiento del dolor.
MY175764A (en) Extended-release formulation for reducing the frequency of urination and method of use thereof
MX2016006179A (es) Formulaciones de capsaicinoides basadas en agua y metodos de manufactura y uso.
MX2013006319A (es) Composiciones y metodos para tratar el cancer usando un inhibidor de pi3k y un inhibidor de mek.
WO2011044523A3 (en) Compositions and methods for treating obesity
IN2014MN02269A (es)
WO2010030976A3 (en) Methods and compositions for inhibiting atherosclerosis and vascular inflammation
MX2010013790A (es) Composiciones y metodos para tratar inflamacion de corneas.
MY171526A (en) Pharmaceutical formulation for reducing frequency of urination and method of use thereof
WO2013083826A3 (en) Glp-1 agonists
MX2012007234A (es) Nanocristales de monohidrato de calciprotiol.
WO2009155070A3 (en) Compositions and methods for treatment of inflammation and hyperkeratotic lesions
GB201022049D0 (en) Methods
NZ603331A (en) Therapeutic regimens and methods for treating or ameliorating visual disorders associated with an endogenous retinoid deficiency

Legal Events

Date Code Title Description
FG Grant or registration